Danaher Corporation (NYSE:DHR) target price raised to $86.00, reported today by Zacks Investment Research
- Updated: September 27, 2016
Danaher Corporation (NYSE:DHR) had its target price raised to $86.00 by Zacks Investment Research in an issued report announced 9/27/2016. The latest stock price target indicates a possible upside of 0.11% based on the company's most recent close.
On 9/12/2016, Vetr Inc. released a statement on Danaher Corporation (NYSE:DHR) bumped up the target price from $0.00 to $81.69 that suggested an upside of 0.06%.
Boasting a price of $77.36, Danaher Corporation (NYSE:DHR) traded 1.31% higher on the day. With the last close up 1.76% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Danaher Corporation has recorded a 50-day average of $79.57 and a two hundred day average of $76.26. Volume of trade was down over the average, with 1,979,702 shares of DHR changing hands under the typical 3,445,570
With a total market value of $0, Danaher Corporation has price-earnings ratio of 15.43 with a one year low of $61.60 and a one year high of $82.64 .
A total of 20 analysts have released a research note on DHR. Nine analysts rating the company a strong buy, six analysts rating the company a buy, eight analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a one year target of $104.22.
More About Danaher Corporation (NYSE:DHR)
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world's food supply, improve packaging design and quality, and verify pharmaceutical dosages.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.